Next-generation CGM and insulin pump

Novo Nordisk to discontinue Levemir, impacting patients who rely on its unique dosing flexibility for diabetes management.

Phase 2 trial of BMF-219 by Biomea Fusion studies insulin sensitivity and beta cell regeneration in Type 1 Diabetes, aiming to transform treatment.

Explore how patients like Stevie Rogers use communication, health diaries, and tech to manage diabetes effectively and improve healthcare collaboration.

Explore the benefits of plant-based proteins for diabetes management. Learn about options like tofu and tempeh to reduce saturated fat intake, control blood sugar,...

A new TikTok trend touts that "...

Discover how CGMs revolutionize diabetes management with personal stories, highlighting the life-changing benefits of devices like Dexcom G6.

Explore Zucara Therapeutics' study on ZT-01, aiming to reduce night-time hypoglycemia in type 1 diabetes by enhancing glucagon production. Join if you meet the...